4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-007724
Chief Operating Officer sold 18,192 shares at $0.84 ($15,281)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2023-03-10 | Sale | −18,192 | $0.84 | $15,281 | 152,714 | D |
| Open-market sales · 18,192 sh · avg $0.84 · $15,281 | |||||||
Loading xslF345X03/wf-form4_167874073622856.xml…